Windemuller Fernando, Xu Jiliu, Rabinowitz Simon S, Hussain M Mahmood, Schwarz Steven M
Fernando Windemuller, Jiliu Xu, Simon S Rabinowitz, Steven M Schwarz, Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, State University of New York Downstate Medical Center, Brooklyn, NY 11203, United States.
World J Hepatol. 2016 Jul 18;8(20):838-43. doi: 10.4254/wjh.v8.i20.838.
To determine whether hepatocyte lipogenesis, in an in vitro cell culture model, is modulated by adjusting culture media monosaccharide content and concentration.
Hepatocytes (Huh7), demonstrating glucose and fructose uptake and lipid biosynthesis, were incubated in culture media containing either glucose alone (0.65-0.72 mmol/L) or isosmolar monosaccharide (0.72 mmol/L) comprising fructose:glucose (F:G) molar ratios ranging from 0.58-0.67. Following a 24-h incubation, cells were harvested and analyzed for total protein, triglyceride (TG) and cholesterol (C) content. Significant differences (P < 0.05) among groups were determined using analysis of variance followed by Dunnett's test for multiple comparisons.
After a 24 h incubation period, Huh7 cell mass and viability among all experimental groups were not different. Hepatocytes cultured with increasing concentrations of glucose alone did not demonstrate a significant change either in C or in TG content. However, when the culture media contained increasing F:G molar ratios, at a constant total monosaccharide concentration, synthesis both of C and of TG increased significantly [F:G ratio = 0.58, C/protein (μg/μg) = 0.13; F:G = 0.67, C/protein = 0.18, P < 0.01; F:G ratio = 0.58, TG/protein (μg/μg) = 0.06; F:G ratio = 0.67, TG/protein = 0.11, P < 0.01].
In an in vitro hepatocyte model, glucose or fructose plus glucose support total cell mass and lipogenic activity. Increasing the fructose:glucose molar ratio (but not glucose alone) enhances triglyceride and cholesterol synthesis. These investigations demonstrate fructose promotes hepatocellular lipogenesis, and they provide evidence supporting future, in vivo studies of fructose's role in the development of hepatic steatosis and non-alcoholic fatty liver disease.
在体外细胞培养模型中,通过调整培养基单糖含量和浓度来确定肝细胞脂肪生成是否受到调节。
选用具有葡萄糖和果糖摄取及脂质生物合成能力的肝细胞(Huh7),将其置于仅含葡萄糖(0.65 - 0.72 mmol/L)或等渗单糖(0.72 mmol/L)的培养基中培养,其中果糖与葡萄糖(F:G)的摩尔比范围为0.58 - 0.67。孵育24小时后,收获细胞并分析其总蛋白、甘油三酯(TG)和胆固醇(C)含量。使用方差分析及随后的Dunnett多重比较检验确定各组间的显著差异(P < 0.05)。
孵育24小时后,所有实验组的Huh7细胞量和活力无差异。单独用浓度递增的葡萄糖培养的肝细胞,其C或TG含量均未显示出显著变化。然而,当培养基中F:G摩尔比增加,总单糖浓度恒定时,C和TG的合成均显著增加[F:G比 = 0.58,C/蛋白(μg/μg) = 0.13;F:G = 0.67,C/蛋白 = 0.18,P < 0.01;F:G比 = 0.58,TG/蛋白(μg/μg) = 0.06;F:G比 = 0.67,TG/蛋白 = 0.11,P < 0.01]。
在体外肝细胞模型中,葡萄糖或果糖加葡萄糖可维持细胞总量和脂肪生成活性。增加果糖与葡萄糖的摩尔比(而非单独增加葡萄糖)可增强甘油三酯和胆固醇的合成。这些研究表明果糖可促进肝细胞脂肪生成,并为未来果糖在肝脂肪变性和非酒精性脂肪性肝病发生中作用的体内研究提供了支持证据。